| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-06 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |